Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial

David O'Connor, MD PhD, Jack Bartram, MD, Amir Enshaei, PhD, Anthony V Moorman, PhD, Christine Harrison, PhDFRCPath FMedSci, Rachel Wade, MSc, Rachel Clack, MSc, Jeremy Hancock, PhD, Sujith Samarasinghe, MD PhD, John Moppett, MD PhD, Ajay J. Vora, Nicholas Goulden, MD PhD

Blood (2015) 126 (23): 1412.

https://doi.org/10.1182/blood.V126.23.1412.1412

Published: 2015

Journal Articles

Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:Â Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003

Jack Bartram, MD, David O'Connor, MD PhD, Amir Enshaei, PhD, Anthony V Moorman, PhD, Christine Harrison, PhDFRCPath FMedSci, Rachel Wade, MSc, Rachel Clack, MSc, Jeremy Hancock, PhD, Sujith Samarasinghe, MD PhD, John Moppett, MD PhD, Ajay J. Vora, Nicholas Goulden, MD PhD

Blood (2015) 126 (23): 806.

https://doi.org/10.1182/blood.V126.23.806.806

Published: 2015

Journal Articles

Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy

Amir Enshaei, PhD, Claire Schwab, Lucy Chilton, PhD, Rachel Wade, MSc, Jeremy Hancock, PhD, Christopher Mitchell, MBBS, PhD FRCP, Sally E Kinsey, Nicholas Goulden, MD PhD, Ajay J. Vora, Christine Harrison, PhDFRCPath FMedSci, Anthony V. Moorman, PhD

Blood (2015) 126 (23): 805.

https://doi.org/10.1182/blood.V126.23.805.805

Published: 2015

Journal Articles

Analysis of Long-Term Outcomes, Management and Prevalence of Osteonecrosis in UKALL 2003: 3.5% of Adolescents and Young Adults over 10 Years of Age with Acute Lymphoblastic Leukaemia Required Hip Replacement

Nadia L Amin, MBChB, MSc, MA, Sally Kinsey, MD FRCP, FRCPath, Richard Feltbower, PhD MSc, BSc, Ajay J. Vora, Nicholas Goulden, MD PhD, Rachel Wade, MSc, Chris Mitchell, FRCPCH, Rachael Hough, MDBMBS,FRCP,FRCPath, Clare Rowntree, PhD, Beki James, PhD MBChB, MA

Blood (2015) 126 (23): 2083.

https://doi.org/10.1182/blood.V126.23.2083.2083

Published: 2015

Journal Articles

No Evidence That PTEN Abnormalities Impact on Outcome in Pediatric Patients with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated on the MRC UKALL2003 Trial

Sarah Jenkinson, MSc, Amy A Kirkwood, Nicholas Goulden, MD PhD, Ajay J. Vora, Chris Mitchell, Rachel Wade, Jeremy Hancock, Anthony V. Moorman, PhD, David C Linch, FMedSci, Rosemary E Gale

Blood (2014) 124 (21): 1077.

https://doi.org/10.1182/blood.V124.21.1077.1077

Published: 2014

Journal Articles

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

Katharine Patrick, Rachel Wade, Nicholas Goulden, MD PhD, Chris Mitchell, Clare Rowntree, FRCPath, Jeremy Hancock, Rachael E Hough, MD, Ajay J. Vora, FRCPath

Blood (2014) 124 (21): 3702.

https://doi.org/10.1182/blood.V124.21.3702.3702

Published: 2014

Journal Articles

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia

Anthony V. Moorman, Amir Enshaei, Claire Schwab, Rachel Wade, Lucy Chilton, Alannah Elliott, Stacey Richardson, Jeremy Hancock, Sally E. Kinsey, Christopher D. Mitchell, Nicholas Goulden, Ajay Vora, Christine J. Harrison

Blood (2014) 124 (9): 1434–1444.

https://doi.org/10.1182/blood-2014-03-562918

Published: 2014

Includes: Supplemental data

Journal Articles

Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003

David O’Connor, Jessica Bate, Rachel Wade, Rachel Clack, Sunita Dhir, Rachael Hough, Ajay Vora, Nick Goulden, Sujith Samarasinghe

Blood (2014) 124 (7): 1056–1061.

https://doi.org/10.1182/blood-2014-03-560847

Published: 2014

Includes: Supplemental data

Journal Articles

Excellent Outcome Of MRD Low Risk Patients Is Sustained With Greater Than 10 Years Follow Up – Results Of UK ALL Trials 1997 -2003

Jack Bartram, Rachel Clack, Rachel Wade, Ajay J Vora, Jeremy Hancock, Chris Mitchell, Sally Kinsey, Colin Steward, John P Moppett, MD, PhD, Nicholas Goulden

Blood (2013) 122 (21): 2635.

https://doi.org/10.1182/blood.V122.21.2635.2635

Published: 2013

Journal Articles

Characteristics and Outcome Of Children and Young Adults With Early T-Precusor (ETP) ALL Treated On UKALL 2003

Katharine Patrick, FRCPath, Rachel Wade, Nicholas Goulden, Chris Mitchell, PhD, Clare Rowntree, FRCPath, Rachael E Hough, MD, Ajay J Vora

Blood (2013) 122 (21): 58.

https://doi.org/10.1182/blood.V122.21.58.58

Published: 2013

Journal Articles

Integration Of Cytogenetic and Copy Number Alteration (CNA) Data Into a Single Risk Profile For Paediatric Acute Lymphoblastic Leukaemia (ALL)

Anthony V. Moorman, Amir Enshaei, Claire Schwab, BSc, Lucy Chilton, Rachel Wade, Nicholas Goulden, Ajay J Vora, Christine J Harrison, PhD

Blood (2013) 122 (21): 1308.

https://doi.org/10.1182/blood.V122.21.1308.1308

Published: 2013

Journal Articles

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Clare Rowntree, PhD, Rachael E Hough, MD, Rachel Wade, Nicholas Goulden, Chris Mitchell, PhD, Ajay J Vora

Blood (2013) 122 (21): 57.

https://doi.org/10.1182/blood.V122.21.57.57

Published: 2013

Journal Articles

Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003

Katharine Patrick, FRCPath, Rachel Wade, MSc, Nicholas Goulden, Clare Rowntree, FRCPath, Rachael Hough, FRCPath, Christopher D Mitchell, FRCPCH, Ajay J Vora

Blood (2013) 122 (21): 56.

https://doi.org/10.1182/blood.V122.21.56.56

Published: 2013

Journal Articles

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Rachael E. Hough, MD, Clare Rowntree, Rachel Wade, Nicholas Goulden, Chris Mitchell, Ajay J. Vora

Blood (2013) 122 (21): 840.

https://doi.org/10.1182/blood.V122.21.840.840

Published: 2013

Journal Articles

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Blood (2012) 120 (4): 843–846.

https://doi.org/10.1182/blood-2012-03-413591

Published: 2012

Includes: Supplemental data

Journal Articles

Outcome of Thrombosis in UKALL 2003- Anticoagulation and Re- Exposure to Aspariginase Is Feasible and Safe.

Amrana Qureshi, Sue Richards, Ajay J. Vora, Christopher D Mitchell, Rachel Wade, Nicholas Goulden

Blood (2008) 112 (11): 900.

https://doi.org/10.1182/blood.V112.11.900.900

Published: 2008

Journal Articles

Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion

David Gonzalez, PhD, Pilar Martinez, MD, PhD, Rachel Wade, Sarah Lorna Hockley, PhD, Vasantha Brito-Babapulle, PhD, David Graham Oscier, MD, Estella Matutes, MD, PhD, Claire E Dearden, Sue Richards, Daniel Catovsky, MD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 784.

https://doi.org/10.1182/blood.V112.11.784.784

Published: 2008

Journal Articles

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003.

Ajay Vora, Rachel Wade, Christopher D Mitchell, Nicholas Goulden, Sue Richards

Blood (2008) 112 (11): 908.

https://doi.org/10.1182/blood.V112.11.908.908

Published: 2008

Journal Articles

Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003.

Ajay Vora, Rachel Wade, Christopher Mitchell, Nicholas Goulden, Sue Richards

Blood (2008) 112 (11): 909.

https://doi.org/10.1182/blood.V112.11.909.909

Published: 2008

Journal Articles

Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003.

Ajay Vora, Rachel Wade, Christopher Mitchell, Nicholas Goulden, Sue Richards

Blood (2008) 112 (11): 910.

https://doi.org/10.1182/blood.V112.11.910.910

Published: 2008

NARROW

Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial

Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:Â Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003

Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy

Analysis of Long-Term Outcomes, Management and Prevalence of Osteonecrosis in UKALL 2003: 3.5% of Adolescents and Young Adults over 10 Years of Age with Acute Lymphoblastic Leukaemia Required Hip Replacement

No Evidence That PTEN Abnormalities Impact on Outcome in Pediatric Patients with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated on the MRC UKALL2003 Trial

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia

Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003

Excellent Outcome Of MRD Low Risk Patients Is Sustained With Greater Than 10 Years Follow Up – Results Of UK ALL Trials 1997 -2003

Characteristics and Outcome Of Children and Young Adults With Early T-Precusor (ETP) ALL Treated On UKALL 2003

Integration Of Cytogenetic and Copy Number Alteration (CNA) Data Into a Single Risk Profile For Paediatric Acute Lymphoblastic Leukaemia (ALL)

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Characteristics and Outcomes Of Patients With Down Syndrome Associated Acute Lymphoblastic Leukaemia Treated On UKALL 2003

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Outcome of Thrombosis in UKALL 2003- Anticoagulation and Re- Exposure to Aspariginase Is Feasible and Safe.

Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003.

Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003.

Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only